The Effectiveness of Dynamic Taping in Preventing Muscle Fatigue

NCT ID: NCT04504929

Last Updated: 2024-03-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-10-01

Study Completion Date

2021-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the efficacy of dynamic tape in prevent shoulder muscle fatigue.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After being informed about the study and the potential of risk, all participants will undergo a screening to determine eligibility for study entry and giving written informed consent.

We will include 20 participants who have pitch 100 times with dynamic taping or shame taping in randomized sequence. There must be more than 2 weeks resting between 2 test. We will test maximal force in shoulder flexion, extension, abduction and adduction before and after test. We also record spins and speed of baseball for performance outcome.

To our hypothesis, we suggest dynamic taping could decrease the arm fatigue after long-term pitching.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fatigue; Muscle, Heart Shoulder Pain Sport Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sham tape

participants received sham taping during pitching, and removed after pitching

Group Type SHAM_COMPARATOR

Sham tape

Intervention Type DEVICE

Use sham type on the pitching shoulder

Dynamic tape

participants received dynamic taping during pitching, and removed after pitching

Group Type EXPERIMENTAL

Dynamic tape

Intervention Type DEVICE

Use dynamic type on the pitching shoulder for supporting internal rotation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sham tape

Use sham type on the pitching shoulder

Intervention Type DEVICE

Dynamic tape

Use dynamic type on the pitching shoulder for supporting internal rotation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* more than 20 years old
* amateur baseball player
* could tolerate pitching 100 times

Exclusion Criteria

* shoulder pain who could not tolerate 100 pitching
* upper limb surgery history
* Allergy to topical agent
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Taipei Medical University WanFang Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

YuHsaun Cheng, Master

Role: PRINCIPAL_INVESTIGATOR

Taipei Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Taipei Medical University

Taipei, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

N201912094

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.